Shape the Future of Delirium Research!
The organizing committee of the Delirium Conference 2025 invites passionate researchers to present their latest findings and innovative approaches in delirium research and healthcare. Our goal is to foster interdisciplinary dialogue, share knowledge, and spark fresh ideas in the field.
We offer the opportunity to showcase original studies through engaging oral presentations and interactive poster sessions. We value a platform that highlights scientific excellence and encourages creativity and forward-thinking approaches.


Seize the opportunity to share your research with a diverse, interdisciplinary audience and drive forward groundbreaking ideas in delirium research!
We will only select abstracts that showcase high-quality, original research for presentation. Please note that case reports are not eligible for submission. The review process will be conducted confidentially, and all decisions regarding acceptance are final.
Each abstract will undergo a thorough evaluation by the EDA scientific committee based on the following criteria:
- Background/Aims: Clearly outline the context and objectives of your research.
- Methods: Describe the methodology used in your study.
- Results: Present the key findings of your research.
- Conclusions: Summarize the implications of your results.
Submission Guidelines:
- File Format: Submissions should be in Word or PDF format.
- Language: All submissions must be in English.
- Structure: Abstracts should be organized under these headings: Background/Aims, Methods, Results, Conclusions.
- Word Limit: Each abstract should not exceed 250 words.
- Title Limit: Titles should be limited to 150 characters.
- Supplementary Materials: You may include up to 2 graphs, charts, or tables to support your findings.
Important Dates:
The window for abstract submissions will remain open until September 1, 2025 (23:59 CET). Authors will receive notifications regarding the selection results by the first week of October 2025, indicating whether their abstract has been accepted or rejected.
We look forward to your innovative contributions!